Reclast, also known by its generic name zoledronic acid, is an intravenous medication used to treat osteoporosis [1]. It belongs to a class of drugs called bisphosphonates, which work by slowing down bone loss [2].
How do Reclast injections work for osteoporosis?
Reclast works by inhibiting osteoclasts, the cells responsible for breaking down bone tissue [3]. By reducing bone resorption, Reclast helps to increase bone mineral density and reduce the risk of fractures in individuals with osteoporosis [2]. It is typically administered as an infusion over at least 15 minutes once a year for postmenopausal women with osteoporosis and every two years for men with osteoporosis [1].
Who should consider Reclast for osteoporosis?
Reclast is prescribed for individuals diagnosed with osteoporosis, particularly postmenopausal women and men at high risk of fractures [1]. It is also used to treat Paget's disease of bone and to prevent skeletal-related events in patients with bone metastases from solid tumors [4].
What are the potential side effects of Reclast?
Common side effects of Reclast can include flu-like symptoms, fever, muscle pain, headache, and fatigue following the infusion [1]. More serious, though less common, side effects can include kidney problems, severe bone, joint, or muscle pain, and osteonecrosis of the jaw (ONJ), a condition where bone tissue in the jaw dies [1][5]. There is also a risk of atypical femur fractures [5].
How long does Reclast treatment typically last?
The duration of Reclast treatment varies depending on the individual's response and risk factors. For postmenopausal osteoporosis, it is typically given once a year. For men with osteoporosis, it is given every two years. The total treatment course may be several years, and a healthcare provider will determine the appropriate length of therapy [1].
Can Reclast be used for other bone conditions?
Yes, in addition to osteoporosis, Reclast is used to treat Paget's disease of bone [4]. It is also administered to patients with certain types of cancer to prevent bone complications, such as fractures, spinal cord compression, and the need for radiation or surgery to bone [4].
What is the difference between Reclast and other osteoporosis medications?
Reclast is an intravenous bisphosphonate, differentiating it from oral bisphosphonates like alendronate (Fosamax) or risedronate (Actonel) [2]. Its intravenous administration may be preferred by some patients due to less frequent dosing compared to daily or weekly oral medications. Other osteoporosis treatments include hormone therapy, other types of bone-building medications, and supplements like calcium and vitamin D [2].
When does Reclast's patent expire?
Information regarding specific patent expiration dates for Reclast can be found on resources such as DrugPatentWatch.com [6]. These dates are crucial for determining when generic versions of the drug may become available.
Who manufactures Reclast?
Reclast is manufactured by Novartis Pharmaceuticals [1].
Sources:
[1] https://www.uniteddrugstore.md/reclast
[2] https://www.mayoclinic.org/diseases-conditions/osteoporosis/diagnosis-treatment/drc-20352879
[3] https://www.rheumatology.org/patients/osteoporosis/bisphosphonates
[4] https://www.drugs.com/reclast.html
[5] https://www.fda.gov/media/73590/download
[6] https://drugpatentwatch.com/